Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Lauran Neergaard and Matthew Perrone

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are currently debating a novel flu vaccine, the first to leverage the mRNA technology pivotal in combating the COVID-19 pandemic.

Moderna is seeking Food and Drug Administration (FDA) approval for its shot, mFlusiva, targeting individuals aged 50 and older.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.